glp-1 weight loss study Virta Health announces first-of-its-kind peer-reviewed proving its approach is an effective off-ramp from GLP-1s for sustained Real-world studies of GLP-1 discontinuation

A 20% relative risk reduction in MACE, including myocardial infarction, stroke, and cardiovascular death and a 30% relative risk reduction in hospitalizations for HF ( The VERTIS trial, involving 8246 patients with T2DM, compared ertugliflozin 5 mg or 15 mg daily to placebo for 3.5 years

As follicles become sensitive to dihydrotestosterone (DHT), their growth cycles progressively shrink

Thanks for laying it out clearly, especially the part about correlation vs causation

Predrag Satiric of Croatia

Specialists in Oxygen Therapy & CPAP Plus 50,000+ Medical Supplies 1800 Medical Supply Oxygen Concentrators, CPAP Machines & Home Medical Equipment Authorized dealer for Inogen, ResMed, Philips Respironics, and CAIRE